Health Care & Life Sciences » Pharmaceuticals | Extrawell Pharmaceutical Holdings Ltd.

Extrawell Pharmaceutical Holdings Ltd. | Balance Sheet

Fiscal year is April-March. All values HKD Millions.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
124
172
204
240
184
172
Total Accounts Receivable
91
62
64
39
26
20
Inventories
9
17
6
10
6
6
Other Current Assets
11
3
1
1
2
11
Total Current Assets
234
254
275
290
218
209
Net Property, Plant & Equipment
173
176
162
146
155
141
Total Investments and Advances
9
686
698
709
809
801
Long-Term Note Receivable
7
10
13
17
23
34
Intangible Assets
286
2
2
2
2
2
Other Assets
11
11
10
9
10
9
Total Assets
720
1,139
1,161
1,173
1,217
1,196
Accounts Payable
13
13
11
15
7
Income Tax Payable
33
29
16
15
16
Other Current Liabilities
76
75
88
79
81
Total Current Liabilities
123
117
115
109
104
Long-Term Debt
533
537
542
548
554
Deferred Taxes
-
-
-
-
-
Other Liabilities
18
-
-
3
4
Total Liabilities
674
655
657
659
662
Common Equity (Total)
89
480
505
517
559
Total Shareholders' Equity
89
480
505
517
559
Total Equity
46
484
504
513
555
Liabilities & Shareholders' Equity
720
1,139
1,161
1,173
1,217
Accumulated Minority Interest
135
4
1
4
4

About Extrawell Pharmaceutical Holdings

View Profile
Address
Suites 2206-08, 22/F
Hong Kong
Hong Kong
Employees -
Website http://www.extrawell.com.hk
Updated 07/08/2019
Extrawell Pharmaceutical Holdings Ltd. engages in the marketing and distribution of pharmaceutical products. It operates through the following segments: Manufacturing, Trading, and Gene Development. The Manufacturing segment includes the development, manufacture, and sale of pharmaceutical products.